Achmea Investment Management B.V. Sells 12,743 Shares of Aflac Incorporated (NYSE:AFL)

Achmea Investment Management B.V. cut its stake in Aflac Incorporated (NYSE:AFL) by 4.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 295,646 shares of the financial services provider’s stock after selling 12,743 shares during the period. Achmea Investment Management B.V. owned 0.05% of Aflac worth $30,581,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Aflac by 6.4% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,694,511 shares of the financial services provider’s stock worth $524,846,000 after buying an additional 281,148 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in Aflac by 1.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,226,681 shares of the financial services provider’s stock worth $333,768,000 after buying an additional 47,119 shares during the period. Amundi lifted its holdings in Aflac by 81.1% in the fourth quarter. Amundi now owns 2,753,513 shares of the financial services provider’s stock worth $285,181,000 after buying an additional 1,232,683 shares during the period. Guinness Asset Management LTD lifted its holdings in Aflac by 5.2% in the fourth quarter. Guinness Asset Management LTD now owns 2,395,045 shares of the financial services provider’s stock worth $247,682,000 after buying an additional 118,720 shares during the period. Finally, Assetmark Inc. lifted its holdings in Aflac by 2.0% in the fourth quarter. Assetmark Inc. now owns 1,616,772 shares of the financial services provider’s stock worth $167,239,000 after buying an additional 32,220 shares during the period. 67.44% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, EVP Audrey B. Tillman sold 24,744 shares of Aflac stock in a transaction on Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the sale, the executive vice president now directly owns 222,618 shares in the company, valued at approximately $23,018,701.20. The trade was a 10.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Charles D. Lake II sold 29,802 shares of the firm’s stock in a transaction on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the transaction, the director now directly owns 49,962 shares of the company’s stock, valued at approximately $5,360,422.98. This trade represents a 37.36 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 55,546 shares of company stock valued at $5,863,616 in the last ninety days. 0.90% of the stock is owned by company insiders.

Aflac Price Performance

Shares of AFL opened at $104.67 on Thursday. The company has a market capitalization of $57.21 billion, a P/E ratio of 10.90, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The firm has a 50 day moving average of $105.24 and a 200 day moving average of $107.70. Aflac Incorporated has a twelve month low of $79.31 and a twelve month high of $115.50.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, equities research analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. StockNews.com upgraded shares of Aflac from a “sell” rating to a “hold” rating in a report on Friday, February 14th. Keefe, Bruyette & Woods lowered their target price on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a report on Wednesday, February 12th. JPMorgan Chase & Co. lifted their target price on shares of Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a report on Tuesday, January 7th. Evercore ISI lowered their target price on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a report on Wednesday, December 4th. Finally, Piper Sandler lowered their target price on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a report on Friday, February 7th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $103.36.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.